Onconova Therapeutics Company Profile (NASDAQ:ONTX)

About Onconova Therapeutics

Onconova Therapeutics logoOnconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The Company's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ONTX
  • CUSIP:
Key Metrics:
  • Previous Close: $3.10
  • 50 Day Moving Average: $3.24
  • 200 Day Moving Average: $4.48
  • 52-Week Range: $6,340,000.00 - $2.62
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.07
  • P/E Growth: 0.00
  • Market Cap: $19.65M
  • Outstanding Shares: 6,340,000
  • Beta: -0.19
Profitability:
  • Net Margins: -102.42%
  • Return on Equity: -256.32%
  • Return on Assets: -71.81%
Debt:
  • Current Ratio: 1.76%
  • Quick Ratio: 1.76%
Additional Links:
Companies Related to Onconova Therapeutics:

Analyst Ratings

Consensus Ratings for Onconova Therapeutics (NASDAQ:ONTX) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $33.67 (986.02% upside)

Analysts' Ratings History for Onconova Therapeutics (NASDAQ:ONTX)
Show:
DateFirmActionRatingPrice TargetDetails
8/19/2016Maxim GroupReiterated RatingBuy$6.00View Rating Details
3/29/2016HC WainwrightReiterated RatingBuyView Rating Details
12/9/2015Piper Jaffray Cos.Reiterated RatingOverweight$60.00View Rating Details
8/28/2015Janney Montgomery ScottReiterated RatingNeutral -> Fair Value$30.00 -> $15.20View Rating Details
2/3/2015Leerink SwannDowngradeOutperform -> Market PerformView Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Onconova Therapeutics (NASDAQ:ONTX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2016        
8/15/2016Q2($1.96)$2.25 millionViewN/AView Earnings Details
5/12/2016Q1($0.19)($0.27)ViewN/AView Earnings Details
3/28/2016Q4($0.27)$0.18ViewN/AView Earnings Details
11/11/2015Q3($0.32)($0.26)ViewN/AView Earnings Details
8/13/2015Q2($0.56)($0.41)ViewN/AView Earnings Details
5/14/2015Q1($0.63)($0.57)ViewN/AView Earnings Details
3/26/2015($0.71)($0.62)ViewN/AView Earnings Details
11/13/2014($0.78)($0.69)ViewN/AView Earnings Details
8/13/2014($0.89)($0.77)ViewN/AView Earnings Details
5/12/2014($0.78)($0.87)ViewN/AView Earnings Details
3/10/2014Q4 13($1.07)($0.68)$1.07 million$1.93 millionViewN/AView Earnings Details
11/12/2013Q3($0.66)($1.34)$1.07 million$1.12 millionViewListenView Earnings Details
9/6/2013Q213($5.21)$0.22 million$0.59 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Onconova Therapeutics (NASDAQ:ONTX)
Current Year EPS Consensus Estimate: $-2.15 EPS
Next Year EPS Consensus Estimate: $-2.91 EPS

Dividends

Dividend History for Onconova Therapeutics (NASDAQ:ONTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Onconova Therapeutics (NASDAQ:ONTX)
Insider Ownership Percentage: 27.30%
Institutional Ownership Percentage: 2.36%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/21/2014& Jane Hoffman 2013 De Michaelmajor shareholderBuy143,480$8.47$1,215,275.60View SEC Filing  
2/10/2014Ramesh KumarCEOSell33,543$15.07$505,493.01View SEC Filing  
2/3/2014Ramesh KumarCEOSell60,000$15.05$903,000.00View SEC Filing  
1/27/2014Michael HoffmanDirectorBuy57,295$11.92$682,956.40View SEC Filing  
11/22/2013Michael HoffmanDirectorBuy5,000$14.39$71,950.00View SEC Filing  
11/18/2013E Premkumar ReddyDirectorBuy5,000$12.10$60,500.00View SEC Filing  
11/15/2013& Jane Hoffman 2013 De Michaelmajor shareholderBuy19,700$11.99$236,203.00View SEC Filing  
11/15/2013Henry BienenDirectorBuy1,400$12.17$17,038.00View SEC Filing  
11/15/2013Ramesh KumarCEOBuy1,100$12.02$13,222.00View SEC Filing  
7/30/2013& Jane Hoffman 2013 De MichaelMajor ShareholderBuy1,000,000$15.00$15,000,000.00View SEC Filing  
7/30/2013Ramesh KumarCEOBuy6,667$15.00$100,005.00View SEC Filing  
7/30/2013Thomas J MckearnInsiderBuy3,333$15.00$49,995.00View SEC Filing  
7/30/2013Viren MehtaDirectorBuy16,667$15.00$250,005.00View SEC Filing  
7/25/2013E Premkumar ReddyDirectorBuy1,000$22.72$22,720.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Onconova Therapeutics (NASDAQ:ONTX)
DateHeadline
investornewswire.com logoShares Of Onconova Therapeutics, Inc. (NASDAQ:ONTX) Expected To Hit $6 - Investor Newswire (NASDAQ:ONTX)
www.investornewswire.com - September 23 at 11:20 AM
News IconUnder the Microscope, Zeroing in at Onconova Therapeutics, Inc. (NASDAQ:ONTX) - Duncan Research (NASDAQ:ONTX)
www.duncanindependent.com - September 22 at 6:17 PM
News IconPenny Stock Investors Take an Interest in Onconova Therapeutics, Inc. (NASDAQ:ONTX) - Duncan Research (NASDAQ:ONTX)
www.duncanindependent.com - September 21 at 6:12 PM
News IconWhat's in Onconova Therapeutics Inc After Reaching All-Time Low? - Chester News (NASDAQ:ONTX)
www.chesterindependent.com - September 16 at 10:07 AM
News IconHow Analysts Feel About Onconova Therapeutics Inc After Reaching 52-Week Low? - Chester News (NASDAQ:ONTX)
www.chesterindependent.com - September 14 at 6:42 PM
publicnow.com logoOnconova Therapeutics, Inc. to Present Corporate Updates at Upcoming Investor Conferences (NASDAQ:ONTX)
www.publicnow.com - September 7 at 10:09 AM
investornewswire.com logoCan Shares Of Onconova Therapeutics, Inc. (NASDAQ:ONTX) Get To $6? - Investor Newswire (NASDAQ:ONTX)
www.investornewswire.com - September 1 at 6:34 PM
News IconShares Dropping Lower in Session: Onconova Therapeutics, Inc. (NASDAQ:ONTX) - Post News (NASDAQ:ONTX)
www.kentuckypostnews.com - September 1 at 6:34 PM
News IconOnconova Quietly Terminates 21% of Workforce (NASDAQ:ONTX)
www.biospace.com - September 1 at 9:46 AM
streetinsider.com logoOnconova Therapeutics (ONTX) Announces Job Cuts, Appoints New CFO - StreetInsider.com (NASDAQ:ONTX)
www.streetinsider.com - August 31 at 11:38 AM
bizjournals.com logoMore job cuts at Bucks County biopharm firm (NASDAQ:ONTX)
www.bizjournals.com - August 31 at 11:38 AM
streetinsider.com logoOnconova Therapeutics (ONTX) Announces Job Cuts, Appoints New CFO (NASDAQ:ONTX)
www.streetinsider.com - August 30 at 6:34 PM
capitalcube.com logoETF’s with exposure to Onconova Therapeutics, Inc. : August 30, 2016 (NASDAQ:ONTX)
www.capitalcube.com - August 30 at 6:34 PM
biz.yahoo.com logoONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Director (NASDAQ:ONTX)
biz.yahoo.com - August 30 at 6:34 PM
investornewswire.com logoOnconova Therapeutics, Inc. (NASDAQ:ONTX) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ONTX)
www.investornewswire.com - August 25 at 6:39 PM
News IconStock Moving Up in Session: Onconova Therapeutics, Inc. (NASDAQ:ONTX) - Post News (NASDAQ:ONTX)
www.kentuckypostnews.com - August 22 at 6:38 PM
News IconOnconova Therapeutics Inc. (NASDAQ: ONTX) Buy Rating Reiterated at Maxim Group - BNB Daily (blog) (NASDAQ:ONTX)
www.baseball-news-blog.com - August 22 at 6:38 PM
News IconOnconova Therapeutics, Inc.'s (ONTX): Stock Alert - Hot Stocks Point (NASDAQ:ONTX)
www.hotstockspoint.com - August 19 at 6:35 PM
investornewswire.com logoWill Onconova Therapeutics, Inc. (NASDAQ:ONTX) Hit $6 Price Target? - Investor Newswire (NASDAQ:ONTX)
www.investornewswire.com - August 19 at 6:35 PM
News IconOnconova Therapeutics Inc (NASDAQ:ONTX) Looks Risky - Street Register (NASDAQ:ONTX)
streetregister.com - August 19 at 6:35 PM
capitalcube.com logoETF’s with exposure to Onconova Therapeutics, Inc. : August 19, 2016 (NASDAQ:ONTX)
www.capitalcube.com - August 19 at 6:35 PM
News IconOnconova Therapeutics Inc (NASDAQ:ONTX) Looks Risky (NASDAQ:ONTX)
streetregister.com - August 18 at 9:43 AM
News IconMy Watchlist for Thursday, August 18 (NASDAQ:ONTX)
ac-investor.blogspot.com - August 17 at 6:56 PM
live-pr.com logoNew Market Research Report: Onconova Therapeutics, Inc. (ONTX) - Financial and Strategic SWOT Analysis Review (NASDAQ:ONTX)
www.live-pr.com - August 16 at 6:48 PM
nasdaq.com logoOnconova Therapeutics, Inc. Reports Recent Business Highlights and Second Quarter 2016 Financial Results (NASDAQ:ONTX)
www.nasdaq.com - August 15 at 6:58 PM
biz.yahoo.com logoONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a (NASDAQ:ONTX)
biz.yahoo.com - August 15 at 6:58 PM
finance.yahoo.com logoOnconova Therapeutics, Inc. Announces Timing for Second Quarter 2016 Financial Results (NASDAQ:ONTX)
finance.yahoo.com - August 11 at 9:53 AM
finance.yahoo.com logoONCONOVA THERAPEUTICS, INC. Financials (NASDAQ:ONTX)
finance.yahoo.com - August 5 at 6:51 PM
bizjournals.com logoBucks County biopharm firm closes $17.4M rights offering (NASDAQ:ONTX)
www.bizjournals.com - August 1 at 6:25 PM
publicnow.com logoOnconova Closes Oversubscribed Rights Offering with Gross Proceeds of $17.4 Million (NASDAQ:ONTX)
www.publicnow.com - August 1 at 8:11 AM
globenewswire.com logoOnconova Announces Expiration of Oversubscribed Rights Offering - GlobeNewswire (press release) (NASDAQ:ONTX)
www.globenewswire.com - July 29 at 9:42 AM
fxpips.com logoOnconova (ONTX), XBiotech (XBIT), Chembio (CEMI) Lead Most Active on Decline (NASDAQ:ONTX)
www.fxpips.com - July 27 at 9:42 AM
publicnow.com logoOnconova Announces Expiration of Oversubscribed Rights Offering (NASDAQ:ONTX)
www.publicnow.com - July 27 at 9:38 AM
globenewswire.com logoOnconova Adjusts Pricing of Rights Offering - GlobeNewswire (press release) (NASDAQ:ONTX)
globenewswire.com - July 22 at 6:31 PM
News IconOnconova Therapeutics Incorporated (NASDAQ:ONTX) Sellers ... - Consumer Eagle (NASDAQ:ONTX)
www.consumereagle.com - July 22 at 6:31 PM
publicnow.com logoOnconova Adjusts Pricing of Rights Offering (NASDAQ:ONTX)
www.publicnow.com - July 22 at 6:08 PM
nasdaq.com logoOnconova Announces Enrollment of First Patient in Japan by SymBio - Nasdaq (NASDAQ:ONTX)
www.nasdaq.com - July 20 at 7:26 PM
ftsenews.co.uk logoNew Broker Ratings For Onconova Therapeutics, Inc. (ONTX) - FTSE News (NASDAQ:ONTX)
www.ftsenews.co.uk - July 20 at 7:26 PM
globenewswire.com logoOnconova Announces Enrollment of First Patient in Japan by SymBio - GlobeNewswire (press release) (NASDAQ:ONTX)
www.globenewswire.com - July 19 at 8:01 AM
finance.yahoo.com logoOnconova Announces Enrollment of First Patient in Japan by SymBio (NASDAQ:ONTX)
finance.yahoo.com - July 19 at 7:01 AM
News IconOnconova Therapeutics Incorporated (NASDAQ:ONTX) Sellers Increased By 163.07% Their Shorts - Consumer Eagle (NASDAQ:ONTX)
www.consumereagle.com - July 18 at 12:03 PM
News IconInstitutional Investor Sentiment About Onconova Therapeutics Inc (NASDAQ:ONTX) Up - Consumer Eagle (NASDAQ:ONTX)
www.consumereagle.com - July 15 at 11:41 AM
News IconIt Seems Onconova Therapeutics Inc Will Go Down. Formed A Few Months Multiple Bottom Pattern - Consumer Eagle (NASDAQ:ONTX)
www.consumereagle.com - July 13 at 6:59 PM
biz.yahoo.com logoONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and (NASDAQ:ONTX)
biz.yahoo.com - July 13 at 4:53 PM
ftsenews.co.uk logoOnconova Therapeutics, Inc. (ONTX) Updated Price Targets - FTSE News (NASDAQ:ONTX)
www.ftsenews.co.uk - July 12 at 6:54 PM
kcregister.com logoToday's Watch List: Onconova Therapeutics, Inc. (NASDAQ:ONTX), PDL BioPharma, Inc. (NASDAQ:PDLI), CompX ... - KC Register (NASDAQ:ONTX)
www.kcregister.com - July 11 at 6:40 PM
News IconOnconova Therapeutics Incorporated (NASDAQ:ONTX) Sellers Increased By 163.07% Their Shorts - Press Telegraph (NASDAQ:ONTX)
presstelegraph.com - July 8 at 6:42 PM
News IconIncreased Volatility on Shares of: Onconova Therapeutics, Inc. (NASDAQ:ONTX) - Engelwood Daily (NASDAQ:ONTX)
www.engelwooddaily.com - July 8 at 6:42 PM
fiscalstandard.com logoOnconova Therapeutics, Inc. (ONTX) Current Analyst Ratings - Fiscal Standard (NASDAQ:ONTX)
www.fiscalstandard.com - July 8 at 6:42 PM
finance.yahoo.com logoOnconova Announces Commencement of Subscription Period for Previously Announced Rights Offering (NASDAQ:ONTX)
finance.yahoo.com - July 8 at 9:20 AM

Social

Onconova Therapeutics (NASDAQ:ONTX) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff